Publication | Closed Access

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Hematological MalignancyLymphoid NeoplasiaOncologyMarrow TransplantationTransplantationOpen LabelMulticentre Phase 2Stem Cell TransplantationHematologyLenalidomide MaintenanceSurgeryCell TransplantationMedicineRadiation OncologyHealth Sciences